Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Nathan Denlinger

Clinical trials sponsored by Nathan Denlinger, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug cocktail aims to boost CAR T-Cell success in lymphoma Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet recruiting 1

Radiation boost may supercharge CAR T-Cell therapy against tough lymphoma

Disease control Not yet recruiting

This trial tests whether adding low-dose total body irradiation (TBI) to standard chemotherapy before CAR T-cell therapy (tisagenlecleucel) is safe and effective for adults with large B-cell lymphoma that has returned or not responded to prior treatments. The study involves 18 pa…

Phase 1 • Sponsor: Nathan Denlinger • Aim: Disease control

Last updated Jul 02, 2026 00:00 UTC